Allogene Therapeutics Inc
ALLO
Market Cap$250.71M
Close$
$-0.08
107.2% downside
Current Fair Value
107.2% downsideOvervalued by 107.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $250.71 Million |
|---|---|
| Enterprise Value | $277.62 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.32 |
| Beta | 0.36 |
| Outstanding Shares | 218,929,548 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.04 |
|---|---|
| PEG | 4.5 |
| Price to Sales | -1.11 |
| Price to Book Ratio | 1.11 |
| Enterprise Value to Revenue | -12619.1 |
| Enterprise Value to EBIT | -1.12 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.29 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Insider Trades
ESG Score
No data